Neuronetrix gets portable EEG FDA nod; JAMA wonders about Theranos;

@FierceMedDev: ICYMI yesterday: Medtronic works to boost neuromodulation with bladder control startup acquisition. Article | Follow @FierceMedDev

@VarunSaxena2: The 10 largest med tech M&A deals announced in 2014. Feature | Follow @VarunSaxena2

@EmilyWFierce: Turning to Twitter, MD Anderson doc launches campaign against cancer drug prices. Story | Follow @EmilyWFierce

> Neuronetrix got FDA clearance for clinical use of its Cognision System, which is a portable device designed for physician office use that records standard electroencephalograms (EEG) as well as auditory event-related potentials. More

> An opinion piece in The Journal of the American Medical Association (JAMA) questions why the scientific community hasn't seen any data out of the much-hyped but stealthy diagnostics company Theranos that aims to cheaply and easily diagnose diseases with only a few drops of blood. Article

> An Idaho lawmaker was schooled on the female anatomy after asking if a woman could swallow a camera to conduct a gynecological exam at a Congressional committee meeting. Story

Biotech News

@FierceBiotech: Novartis bags a surprise approval for the blood cancer-treating panobinostat. Article | Follow @FierceBiotech

@JohnCFierce: Top story yesterday: UPDATED: Bristol-Myers bags IDO immunotherapy in $1.25B buyout of fledgling Flexus. Article | Follow @JohnCFierce

@DamianFierce: MD Anderson has a Houston Rockets sponsorship called "Moon Shot of the Night," because why not. Video | Follow @DamianFierce

> Alkermes dumps its pain drug after a Phase I disappointment. Story

> Cebix hangs it up after raising $50M for diabetes drug. Article

> Shire's shopping spree continues with a buyout of rare disease biotech. Report

Pharma News

@FiercePharma: Baxter U.S. Selects Bannockburn, Ill., Facility as Location for Baxalta Global Headquarters. Release | Follow @FiercePharma

@CarlyHFierce: ICYMI: Canadian paper backpedals from Gardasil side effects story. Report | Follow @CarlyHFierce

> Baxter picks HQ for biopharma spinoff, and it's just up the road. Article

> Takeda makes an M&A move in Turkey. Report

> Actavis' buyout of Allergan could trigger $100M golden parachute for Pyott. Story

Biotech Research News

> MD Anderson team explores a combination approach against cancer metastasis. More

> Study: New antibody blocks dengue virus. Item

> UC San Diego group zeroes in on breaking a link between obesity and diabetes. Story

> Langer team offers up a hydrogel drug delivery vehicle at MIT. Report

> CRISPR project points to a new approach on Duchenne muscular dystrophy. Article

Pharma Manufacturing News

> Sun Pharma recalls epilepsy drug as dissolution woes continue. News

> Mylan bags rights to distribute Gilead's Sovaldi in India. Item

> Lupin plant hit with Form 483 but continues to rack up approvals. Report

> McKesson outed as company behind 340,000-sq-ft distribution hub in Iowa. Story

> India turns to small manufacturers for state-run generic supply biz. Article

Suggested Articles

LabCorp, Philips and Mount Sinai are coming together to develop an AI-driven pathology center of excellence, aimed initially at cancer diagnosis.

The FDA followed through with plans to end its Alternative Summary Reporting program, making 20 years’ worth of device safety data publicly available.

Janssen tapped Resolution Bioscience to develop a companion diagnostic for Zejula in patients with metastatic castration-resistant prostate cancer.